Glycaemic control and hypoglycaemia during 12 months of randomized treatment with insulin glargine 300 U/mL versus glargine 100 U/mL in people with type 1 diabetes (EDITION 4)

AIMS: Insulin glargine 300 U/mL (Gla‐300) offers a flatter pharmacodynamic profile than insulin glargine 100 U/mL (Gla‐100). We have compared these insulins over 1 year in people with type 1 diabetes (T1DM). METHODS: EDITION 4 was a 6‐month, multicentre, randomized, open‐label phase 3 study. People...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Obes Metab
Main Authors: Home, Philip D., Bergenstal, Richard M., Bolli, Geremia B., Ziemen, Monika, Rojeski, Maria, Espinasse, Melanie, Riddle, Matthew C.
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2017
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5763343/
https://ncbi.nlm.nih.gov/pubmed/28661585
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13048
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados